Corvus Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Corvus Pharmaceuticals is a biopharmaceutical company in the clinical stage that is dedicated to creating groundbreaking treatments for cancer by targeting the immune system. We have a team of skilled scientists and strong financial backing, which puts us in a prime position in the evolving field of immuno-oncology.
Corvus Pharmaceuticals has raised $232M across 2 funding rounds on record, the most recent an undisclosed round of $201M announced in Jan 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Corvus Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Corvus Pharmaceuticals Funding Rounds
Corvus Pharmaceuticals raised $30.6M in an undisclosed round announced in May 2024.
1.7 years later, an undisclosed round of $201M was announced in Jan 2026.
Corvus Pharmaceuticals Founders and Leadership Team
Contact details for the Corvus Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Corvus Pharmaceuticals Funding Compared to Other Biotechnology Startups
Corvus Pharmaceuticals' latest round of $201M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Corvus Pharmaceuticals in Biotechnology and Burlingame
Companies Similar to Corvus Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Corvus Pharmaceuticals Funding FAQs
What does Corvus Pharmaceuticals do?
Corvus Pharmaceuticals is a biopharmaceutical company in the clinical stage that is dedicated to creating groundbreaking treatments for cancer by targeting the immune system. We have a team of skilled scientists and strong financial backing, which puts us in a prime position in the evolving field of immuno-oncology.
How much funding has Corvus Pharmaceuticals raised?
Corvus Pharmaceuticals has raised $232M across 2 rounds on record. The most recent is an undisclosed round of $201M announced in Jan 2026.
When did Corvus Pharmaceuticals last raise funding?
Corvus Pharmaceuticals' most recent funding round on record is an undisclosed round of $201M, announced in Jan 2026.
Who founded Corvus Pharmaceuticals?
FundedIQ lists Richard A Miller (Founder) at Corvus Pharmaceuticals.
Where is Corvus Pharmaceuticals headquartered?
Corvus Pharmaceuticals is based in Burlingame, California, United States.
How many employees does Corvus Pharmaceuticals have?
Corvus Pharmaceuticals is in the 11-50 employee band.
How does Corvus Pharmaceuticals' funding compare to other Biotechnology startups?
Corvus Pharmaceuticals' latest round of $201M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Corvus Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Corvus Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.